Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Exclusive News Oklo: The Bottom Is In, and the Upside Potential Is NuclearAuthor: Thomas Hughes. Originally Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profits, but that hasn't stopped investors. The company's fiscal year 2025 (FY2025) progress report and updates indicate it is on track to meet its long-term objectives and market expectations. The market response — including analyst updates after the release — says it all: the absence of near-term revenue is being overlooked in light of the long-term opportunity. Analysts Focus on Oklo's Long-Term Opportunity MarketBeat tracked roughly half a dozen revisions within 12 hours of the release. Those included a single price-target cut, offset by a larger number of affirmed ratings and targets, and no downgrades. The takeaway: the activity fits the broader trend of growing coverage, a steady Moderate Buy rating, a 58% Buy-side bias, and rising price targets. Price targets matter here — consensus suggests more than 50% upside versus mid-March lows. Analysts expressed concern about the 2025 results, but they remain focused on the long-term opportunity and on progress toward Nuclear Regulatory Commission licensing. The company won its first license for its subsidiary, Atomic Alchemy, which will produce isotopes. The license permits the receipt, possession, storage, processing, repackaging, and distribution of up to two curies of radium-226 — roughly two grams. Two grams isn't a large amount, and radium-226 alone is not especially valuable today. Once commonly used in medicine, it is now difficult to handle and remediate. But radium-226 is a precursor to actinium, which is increasingly in demand. Actinium is one of the most expensive elements and is used in specialized cancer treatments that can cost roughly $20,000 per dose. The implication for investors is that Oklo's diversification strategy has been validated and a revenue stream has been opened. It may take a few quarters for material revenue to appear, but that should occur well before the commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Suggest the Bottom Is In Institutional and short-selling data point toward a bottom for Oklo stock. Short interest remains elevated — near 15% as of early March — but it is down from its peak following the stock's October 2025 highs and is likely to continue falling in upcoming reports. Institutional activity moved in the opposite direction, ramping up after Oklo's Q2 2025 decline and reaching record-high levels in early 2026. Currently, institutions own roughly 85% of the float, which provides solid support. They are accumulating at an estimated pace of $3 purchased for each $1 sold. If these trends persist, the available float will shrink over the coming months, making upward price moves more likely. A catalytic news event could even trigger a short squeeze. Dilutive Headwinds Ease in 2026 Shareholder dilution was meaningful in 2025 but has eased heading into 2026. The company's share count is up about 50% year-over-year, and the balance sheet is well capitalized. FY2026 plans imply enough capital at the current project burn rate for roughly two years, giving time for secondary revenue streams — such as the isotope business — to develop. The trade-off is that profitability isn't expected until 2030, so additional capital will likely be required later. The technical setup looks constructive. OKLO stock is well off its highs and appeared oversold in March. The MACD has diverged and turned bullish, and the stochastic oscillator has followed suit, signaling a strong buy at current levels. Whether the market follows through on those signals may take time; the lack of current revenue and profits remains a weight on the stock. The largest risk is execution and delays. The market is pricing in robust growth — effectively valuing the stock at more than 100X its initial-year earnings — and may be intolerant of setbacks. That means Oklo could see significant volatility if milestones slip, even as the broader rebound story plays out. | 
